Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The company also develops ALG-020572, an antisense oligonucleotide to prevent HBsAg translation and secretion; and ALG-055009, a small molecule THR-ß agonist that is in the Phase 1a/1b for the treatment of non-alcoholic steatohepatitis(NASH). In addition, it develops siRNA drug candidate, ALG-125755, as well as ALG-125097 and ALG-125819, demonstrated potent inhibition of HBsAg release from HBV-infected cells. It has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; Emory University to provide hepatitis B virus capsid assembly modulator technology; research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors; and Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH. The company was incorporated in 2018 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aligos Therapeutics Inc..
Aligos Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aligos Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aligos Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aligos Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aligos Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aligos Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aligos Therapeutics Inc.- Key Facts
2.2 Aligos Therapeutics Inc.- Geographic Locations
2.3 Aligos Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Aligos Therapeutics Inc.- Business Divisions
2.5 Aligos Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aligos Therapeutics Inc. Strategic Analysis Review
3.1 Aligos Therapeutics Inc.- Key Strategies
3.2 Aligos Therapeutics Inc.- Company Outlook Statement
3.3 Aligos Therapeutics Inc.- SWOT Analysis
3.3.1 Aligos Therapeutics Inc.- Key Strengths
3.3.2 Aligos Therapeutics Inc.- Key Weaknesses
3.3.3 Aligos Therapeutics Inc.- Potential Opportunities
3.3.4 Aligos Therapeutics Inc.- Potential Threats
3.4 Aligos Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aligos Therapeutics Inc.- Business Overview
4.2 Aligos Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aligos Therapeutics Inc.- Key Products
5.2 Aligos Therapeutics Inc.- Key Service Areas
5.3 Aligos Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Aligos Therapeutics Inc.- Company History
6.2 Aligos Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aligos Therapeutics Inc.- Income Statements
7.2 Aligos Therapeutics Inc.- Balance Sheet
7.3 Aligos Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aligos Therapeutics Inc.- Direct Competitors
8.2 Aligos Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aligos Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aligos Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
